• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Johnson & Johnson

NIH launches drug trial for deadly cytokine storm

October 16, 2020 By Sean Whooley

The National Institutes of Health today launched a Phase 3 clinical trial to evaluate three immune modulator drugs in hospitalized adults with COVID-19. Some COVID-19 patients experience an immune response in which the immune system unleashes proteins that trigger inflammation, otherwise known as a cytokine storm, which can lead to acute respiratory distress syndrome, multiple […]

Filed Under: Business/Financial News, Clinical Trials, Featured, Pharmaceutical Tagged With: AbbVie, Bristol-Myers Squibb Co., coronavirus, COVID-19, Janssen Pharmaceuticals, Johnson & Johnson, National Institutes of Health (NIH)

Vaccine trial pause sees Johnson & Johnson dip despite strong Q3

October 13, 2020 By Sean Whooley

Johnson & Johnson (NYSE:JNJ) shares ticked down despite third-quarter results that came in well ahead of the consensus forecast. News of the company’s COVID-19 vaccine candidate trial being put on pause after a patient illness likely played its part, as shares of JNJ were trading down -2.1% at $148.68 per share in midday trading today. The […]

Filed Under: Business/Financial News, Clinical Trials, Featured, MassDevice Earnings Roundup, Pharmaceutical, Research & Development, Wall Street Beat Tagged With: coronavirus, COVID-19, Johnson & Johnson

J&J halts COVID-19 vaccine trial due to illness

October 13, 2020 By Sean Whooley

Johnson & Johnson (NYSE:JNJ) announced that it temporarily paused further dosing in its COVID-19 vaccine candidate clinical trials. The pause in the trials conducted by J&J’s Janssen Pharmaceuticals subsidiary follows an unexplained illness arising in a study participant, according to a news release. Under the company’s guidelines, the illness is being reviewed and evaluated by internal and independent […]

Filed Under: Clinical Trials, Featured, Pharmaceutical Tagged With: coronavirus, COVID-19, Johnson & Johnson

MedTech 100 roundup: New peak for industry

October 13, 2020 By Sean Whooley

Stocks in the medtech industry continue to impress as, over the past week, they set a new benchmark amid the COVID-19 pandemic. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week at 95.05 (Oct. 9), marking a 5.9% gain from the 89.73 points registered at the […]

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions, Research & Development, Wall Street Beat Tagged With: coronavirus, COVID-19, Edwards Lifesciences, Johnson & Johnson, MedTech 100 Index, Medtronic, Steris Corp.

EU orders 200M J&J COVID-19 vaccine doses

October 8, 2020 By Sean Whooley

Johnson & Johnson (NYSE:JNJ) announced today that its set to provide 200 million doses of its COVID-19 vaccine candidate to Europe. The European Commission, on behalf of the European Union, approved an advance purchase agreement in which J&J subsidiary Janssen Pharmaceutical, which is developing the vaccine candidate, would supply the doses to EU member states following […]

Filed Under: Business/Financial News, Featured, Pharmaceutical Tagged With: coronavirus, COVID-19, Janssen Pharmaceuticals, Johnson & Johnson, Johnson and Johnson

J&J exec denies pressure to rush COVID-19 vaccine

October 8, 2020 By Nancy Crotti

Johnson & Johnson’s (NYSE:JNJ) chief scientific officer said today that the first doses of his company’s COVID-19 vaccine could be available for frontline healthcare workers in January or February, but added the company isn’t rushing it. If granted an emergency use authorization by the FDA, that’s the earliest Dr. Paul Stoffels said the single-dose vaccine developed […]

Filed Under: Clinical Trials, Distribution, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Pharmaceutical, Regulatory/Compliance Tagged With: coronavirus, COVID-19, FDA, Janssen Pharmaceuticals, Johnson & Johnson, vaccines

J&J exec denies pressure to rush COVID-19 vaccine

October 7, 2020 By Nancy Crotti

Johnson & Johnson’s (NYSE:JNJ) chief scientific officer said today that the first doses of his company’s COVID-19 vaccine could be available for frontline healthcare workers in January or February, but added the company isn’t rushing it. If granted an emergency use authorization by the FDA, that’s the earliest Dr. Paul Stoffels said the single-dose vaccine developed […]

Filed Under: Clinical Trials, Distribution, Drug-Device Combinations, Featured, Pharmaceutical, Research & Development Tagged With: coronavirus, COVID-19, FDA, Janssen Pharmaceuticals, Johnson & Johnson

J&J wins FDA approval for ablation catheter

October 7, 2020 By Chris Newmarker

Johnson & Johnson (NYSE:JNJ) recently announced that its Biosense Webster business has secured FDA approval for its Thermocool SmartTouch SF ablation catheter. The Thermocool SmartTouch received approval for the treatment of persistent atrial fibrillation, J&J announced yesterday. Get the full story on our sister site Medical Tubing + Extrusion. 

Filed Under: Cardiovascular, Catheters, Food & Drug Administration (FDA), Pre-Market Approval (PMA), Regulatory/Compliance Tagged With: Biosense Webster, Johnson & Johnson

The top 5 MassDevice stories of the week — September 25, 2020

September 25, 2020 By Chris Newmarker

The past week in medtech saw Boston Scientific (NYSE:BSX) make an interesting move in the Afib space — and much more. Want to hear more about the week’s top news? Executive editor Chris Newmarker and Tom Salemi will discuss the week’s “Newmarker’s Newsmakers” during our DeviceTalks Weekly podcast. Without further ado, here’s this week’s MassDevice Top […]

Filed Under: Business/Financial News, Cardiovascular, Catheters, Featured, Mergers & Acquisitions, Robotics, Surgical Tagged With: Boston Scientific, Farapulse, Intuitive Surgical, Johnson & Johnson, Johnson and Johnson, MassDevice Top Five, Medtronic, robot-assisted, Robotic Surgery

What are the top COVID-19 vaccine candidates?

September 25, 2020 By Nancy Crotti

As of yesterday, five COVID-19 vaccine candidates had begun Phase 3 clinical trials as they seek to determine the safety and efficacy of their formulas. Researchers worldwide are testing 132 COVID-19 vaccine candidates, including 42 that are in clinical trials on humans and at least 92 in preclinical or animal trials, according to the New […]

Filed Under: Business/Financial News, Clinical Trials, Featured, Pharmaceutical, Research & Development Tagged With: AstraZeneca plc, BioNTech, coronavirus, COVID-19, GlaxoSmithKline plc, Johnson & Johnson, Moderna, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Pfizer, Sanofi, U.S. Biomedical Advanced Research and Development Authority (BARDA)

12 surgical robotics companies you need to know

September 22, 2020 By Chris Newmarker

Surgical robotics remains a hot area in medtech — even as it faces headwinds from the COVID-19 pandemic. Intuitive Surgical (NSDQ:ISRG) pioneered robotic surgery through the early 2000s and remains the dominant player, but major companies including Medtronic (NYSE:MDT) and Johnson & Johnson (NYSE:JNJ) have big plans to enter the space and compete. Meanwhile, Stryker (NYSE:SYK) has built a […]

Filed Under: Business/Financial News, Featured, Orthopedics, Robotics, Surgical Tagged With: Corindus Vascular Robotics, Intuitive Surgical, Johnson & Johnson, Johnson and Johnson, Medtronic, Monteris Medical, robot-assisted, Robotic Surgery, Siemens Healthineers, Smith & Nephew, Smith+Nephew, Stereotaxis, Stryker, Titan Medical Inc., TransEnterix, Vicarious Surgical, Zimmer Biomet

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS